Creatine kinase-myocardial band isoenzyme elevation after percutaneous coronary interventions using sirolimus-eluting stents

American Journal of Cardiology

Volumn 93, Issue 11, 2004, Pages 1397-1401

  Stankovic, Goran ^a   Chieffo, Alaide ^a   Iakovou, Ioannis ^a   Orlic, Dejan ^a   Corvaja, Nicola ^a   Sangiorgi, Giuseppe ^a   Airoldi, Flavio ^a   Colombo, Antonio ^a  

^a EMO GVM CENTRO CUORE COLUMBUS   (Italy)

Author keywords

[No Author keywords available]

Indexed keywords

ACETYLSALICYLIC ACID; CLOPIDOGREL; CREATINE KINASE MB; FIBRINOGEN RECEPTOR ANTAGONIST; HEPARIN; ISOENZYME; RAPAMYCIN; TICLOPIDINE;

ACUTE STENT THROMBOSIS; ADULT; AGED; ARTICLE; BLOOD VESSEL OCCLUSION; CONTROLLED STUDY; CORONARY ARTERY DISEASE; CORONARY STENT; CREATINE KINASE BLOOD LEVEL; DISEASE PREDISPOSITION; DRUG ELUTING STENT; DRUG USE; EMBOLISM; FEMALE; FOLLOW UP; HEART INFARCTION; HUMAN; MAJOR CLINICAL STUDY; MALE; METAL IMPLANTATION; POSTOPERATIVE COMPLICATION; PREDICTION; PRIORITY JOURNAL; RESTENOSIS; THROMBOSIS; TRANSLUMINAL CORONARY ANGIOPLASTY; TREATMENT OUTCOME;

ANGIOPLASTY, TRANSLUMINAL, PERCUTANEOUS CORONARY; CORONARY RESTENOSIS; CORONARY STENOSIS; CREATINE KINASE; CREATINE KINASE, MB FORM; DATABASES, FACTUAL; EQUIPMENT DESIGN; FEMALE; HUMANS; IMMUNOSUPPRESSIVE AGENTS; ISOENZYMES; LINEAR MODELS; MALE; MIDDLE AGED; MYOCARDIAL INFARCTION; PLATELET GLYCOPROTEIN GPIIB-IIIA COMPLEX; SIROLIMUS; STENTS; TIME FACTORS;

EID: 2542422850     PISSN: 00029149     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.amjcard.2004.02.039     Document Type: Article

References (15)

1. Morice M.C., Serruys P.W., Sousa J.E., Fajadet J., Ban Hayashi E., Perin M., Colombo A., Schuler G., Barragan P., Guagliumi G., et al. A randomized comparison of a sirolimus-eluting stent with a standard stent for coronary revascularization. N Engl J Med. 346:2002;1773-1780
2. Moses J.W., Leon M.B., Popma J.J., Fitzgerald P.J., Holmes D.R., O'Shaughnessy C., Caputo R.P., Kereiakes D.J., Williams D.O., Teirstein P.S., et al. Sirolimus-eluting stents versus standard stents in patients with stenosis in a native coronary artery. N Engl J Med. 349:2003;1315-1323
3. Schofer J., Schluter M., Gershlick A.H., Wijns W., Garcia E., Schampaert E., Breithardt G. Sirolimus-eluting stents for treatment of patients with long atherosclerotic lesions in small coronary arteries double-blind, randomised controlled trial (E-SIRIUS). Lancet. 362:2003;1093-1099
4. Colombo A., Orlic D., Stankovic G., Corvaja N., Spanos V., Montorfano M., Liistro F., Carlino M., Airoldi F., Chieffo A., Di Mario C. Preliminary observations regarding angiographic pattern of restenosis after rapamycin-eluting stent implantation. Circulation. 107:2003;2178-2180
5. Lemos P.A., Saia F., Ligthart J.M., Arampatzis C.A., Sianos G., Tanabe K., Hoye A., Degertekin M., Daemen J., McFadden E., et al. Coronary restenosis after sirolimus-eluting stent implantation. Morphological description and mechanistic analysis from a consecutive series of cases. Circulation. 108:2003;257-260
6. Degertekin M., Regar E., Tanabe K., Smits P.C., van der Giessen W.J., Carlier S.G., de Feyter P., Vos J., Foley D.P., Ligthart J.M., et al. Sirolimus-eluting stent for treatment of complex in-stent restenosis the first clinical experience. J Am Coll Cardiol. 41:2003;184-189
7. Cutlip D.E., Baim D.S., Ho K.K., Popma J.J., Lansky A.J., Cohen D.J., Carrozza J.P. Jr, Chauhan M.S., Rodriguez O., Kuntz R.E. Stent thrombosis in the modern era a pooled analysis of multicenter coronary stent clinical trials. Circulation. 103:2001;1967-1971
8. Blankenship J.C., Tasissa G., O'Shea J.C., Iliadis E.A., Bachour F.A., Cohen D.J., Lui H.K., Mann T. III, Cohen E., Tcheng J.E. Effect of glycoprotein IIb/IIIa receptor inhibition on angiographic complications during percutaneous coronary intervention in the ESPRIT trial. J Am Coll Cardiol. 38:2001;653-658
9. Stankovic G., Colombo A., Presbitero P., van den Branden F., Inglese L., Cernigliaro C., Niccoli L., Bartorelli A.L., Rubartelli P., Reifart N., et al. Randomized evaluation of polytetrafluoroethylene-covered stent in saphenous vein grafts the Randomized Evaluation of Polytetrafluoroethylene Covered Stent in Saphenous Vein Grafts (RECOVERS) Trial. Circulation. 108:2003;37-42
10. Kini A., Marmur J.D., Kini S., Dangas G., Cocke T.P., Wallenstein S., Brown E., Ambrose J.A., Sharma S.K. Creatine kinase-MB elevation after coronary intervention correlates with diffuse atherosclerosis, and low-to-medium level elevation has a benign clinical course implications for early discharge after coronary intervention. J Am Coll Cardiol. 34:1999;663-671
11. Kanaparti P.K., Brown D.L. Relation between coronary atherosclerotic plaque burden and cardiac enzyme elevation following percutaneous coronary intervention. Am J Cardiol. 86:2000;619-622
12. Mehran R., Dangas G., Mintz G.S., Lansky A.J., Pichard A.D., Satler L.F., Kent K.M., Stone G.W., Leon M.B. Atherosclerotic plaque burden and CK-MB enzyme elevation after coronary interventions intravascular ultrasound study of 2256 patients. Circulation. 101:2000;604-610
13. Topol E.J., Yadav J.S. Recognition of the importance of embolization in atherosclerotic vascular disease. Circulation. 101:2000;570-580
14. Blankenship J.C., Sigmon K.N., Pieper K.S., O'Shea C., Tardiff B.E., Tcheng J.E. Effect of eptifibatide on angiographic complications during percutaneous coronary intervention in the IMPACT (Integrilin to Minimize Platelet Aggregation and Coronary Thrombosis) II Trial. Am J Cardiol. 88:2001;969-973
15. Islam M.A., Blankenship J.C., Balog C., Iliadis E.A., Lincoff A.M., Tcheng J.E., Califf R.M., Topol E.J. Effect of abciximab on angiographic complications during percutaneous coronary stenting in the Evaluation of Platelet IIb/IIIa Inhibition in Stenting Trial (EPISTENT). Am J Cardiol. 90:2002;916-921